The role of catechol-O-methyltransferase in reward processing and addiction

CNS and Neurological Disorders - Drug Targets

Volumn 11, Issue 3, 2012, Pages 306-323

  Tunbridge, E M ^a   Huber, A ^a   Farrell, S M ^a   Stumpenhorst, K ^a   Harrison, P J ^a   Walton, M E ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

COMT; Dopamine; Nucleus accumbens; Prediction error; Smoking; Striatum

Indexed keywords

11 HYDROXYDRONABINOL; ALCOHOL; AMPHETAMINE; CANNABIS; CATECHOL METHYLTRANSFERASE; COCAINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; ILLICIT DRUG; METHIONINE; NEUROTRANSMITTER; VALINE;

ADDICTION; ALCOHOLISM; ANTICIPATION; BRAIN; BRAIN ACTIVATION; BRAIN CORTEX; BRAIN REGION; CELL ACTIVATION; CIGARETTE SMOKING; CORPUS STRIATUM; DECISION MAKING; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; DRUG TARGETING; ENZYME INHIBITION; EXECUTIVE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; ILLICIT DRUG ABUSE; LEARNING; MENTAL TASK; NERVE CELL; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PREFRONTAL CORTEX; REVIEW; REWARD; REWARD PROCESSING; TASK PERFORMANCE; TOBACCO DEPENDENCE; WORKING MEMORY;

EID: 84861726076     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152712800672409     Document Type: Review

References (155)

1. Schultz, W. Dopamine neurons and their role in reward mechanisms. Curr. Opin. Neurobiol., 1997, 7(2), 191-197.
2. Chen, J.; Lipska, B.K.; Halim, N.; Ma, Q.D.; Matsumoto, M.; Melhem, S.; Kolachana, B.S.; Hyde, T.M.; Herman, M.M.; Apud, J.; Egan, M.F.; Kleinman, J.E.; Weinberger, D.R. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet., 2004, 75(5), 807-821.
3. Nackley, A.G.; Shabalina, S.A.; Tchivileva, I.E.; Satterfield, K.; Korchynskyi, O.; Makarov, S.S.; Maixner, W.; Diatchenko, L. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science, 2006, 314(5807), 1930-1933.
4. Gogos, J.A.; Morgan, M.; Luine, V.; Santha, M.; Ogawa, S.; Pfaff, D.; Karayiorgou, M. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl. Acad. Sci. USA, 1998, 95(17), 9991-9996.
5. Yavich, L.; Forsberg, M.M.; Karayiorgou, M.; Gogos, J.A.; Mannisto, P.T. Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. J. Neurosci., 2007, 27(38), 10196-10209.
6. Tunbridge, E.M.; Bannerman, D.M.; Sharp, T.; Harrison, P.J. Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J. Neurosci., 2004, 24(23), 5331-5335.
7. Kaenmaki, M.; Tammimaki, A.; Myohanen, T.; Pakarinen, K.; Amberg, C.; Karayiorgou, M.; Gogos, J.A.; Mannisto, P.T. Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice. J. Neurochem., 2010, 114(6), 1745-1755.
8. Lewis, D.A.; Melchitzky, D.S.; Sesack, S.R.; Whitehead, R.E.; Auh, S.; Sampson, A. Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J. Comp. Neurol., 2001, 432(1), 119-136.
9. Sesack, S.R.; Hawrylak, V.A.; Matus, C.; Guido, M.A.; Levey, A.I. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J. Neurosci., 1998, 18(7), 2697-2708.
10. Kaakkola, S.; Wurtman, R.J. Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study. Brain Res., 1992, 587(2), 241-249.
11. Kellendonk, C.; Simpson, E.H.; Polan, H.J.; Malleret, G.; Vronskaya, S.; Winiger, V.; Moore, H.; Kandel, E.R. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron, 2006, 49(4), 603-615.
12. Pycock, C.J.; Kerwin, R.W.; Carter, C.J. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature, 1980, 286(5768), 74-76.
13. Akil, M.; Kolachana, B.S.; Rothmond, D.A.; Hyde, T.M.; Weinberger, D.R.; Kleinman, J.E. Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J. Neurosci., 2003, 23(6), 2008-2013.
14. Meyer-Lindenberg, A.; Kohn, P.D.; Kolachana, B.; Kippenhan, S.; McInerney-Leo, A.; Nussbaum, R.; Weinberger, D.R.; Berman, K.F. Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat. Neurosci., 2005, 8(5), 594-596.
15. Haber, S.N. The primate basal ganglia: parallel and integrative networks. J. Chem. Neuroanat., 2003, 26(4), 317-330.
16. Budygin, E.A.; Gainetdinov, R.R.; Kilpatrick, M.R.; Rayevsky, K.S.; Mannisto, P.T.; Wightman, R.M. Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake. Eur. J. Pharmacol., 1999, 370(2), 125-131.
17. Tuomainen, P.; Tornwall, M.; Mannisto, P.T. Minor effect of tolcapone, a catechol-O-methyltransferase inhibitor, on extracellular dopamine levels modified by amphetamine or pargyline: a microdialysis study in anaesthetized rats. Pharmacol. Toxicol., 1996, 78(6), 392-396.
18. Bilder, R.M.; Volavka, J.; Lachman, H.M.; Grace, A.A. The catechol-O-methyltransferase polymorphism: relations to the tonicphasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology, 2004, 29(11), 1943-1961.
19. Haber, S.N.; Knutson, B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology, 2010, 35(1), 4-26.
20. Berridge, K.C.; Robinson, T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res. Brain Res. Rev., 1998, 28(3), 309-369.
21. Salamone, J.D.; Correa, M.; Farrar, A.; Mingote, S.M. Effortrelated functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology(Berl.), 2007, 191(3), 461-482.
22. Cannon, C.M.; Palmiter, R.D. Reward without dopamine. J. Neurosci., 2003, 23(34), 10827-10831.
23. Nicola, S.M. The flexible approach hypothesis: unification of effort and cue-responding hypotheses for the role of nucleus accumbens dopamine in the activation of reward-seeking behavior. J. Neurosci., 2010, 30(49), 16585-16600.
24. Gan, J.O.; Walton, M.E.; Phillips, P.E. Dissociable cost and benefit encoding of future rewards by mesolimbic dopamine. Nat. Neurosci., 2010, 13(1), 25-27.
25. Tobler, P.N.; Fiorillo, C.D.; Schultz, W. Adaptive coding of reward value by dopamine neurons. Science, 2005, 307(5715), 1642-1645.
26. Kobayashi, S.; Schultz, W. Influence of reward delays on responses of dopamine neurons. J. Neurosci., 2008, 28(31), 7837-7846.
27. Roesch, M.R.; Calu, D.J.; Schoenbaum, G. Dopamine neurons encode the better option in rats deciding between differently delayed or sized rewards. Nat. Neurosci., 2007, 10(12), 1615-1624.
28. Morris, G.; Nevet, A.; Arkadir, D.; Vaadia, E.; Bergman, H. Midbrain dopamine neurons encode decisions for future action. Nat. Neurosci., 2006, 9(8), 1057-1063.
29. Montague, P.R.; Dayan, P.; Sejnowski, T.J. A framework for mesencephalic dopamine systems based on predictive Hebbian learning. J. Neurosci., 1996, 16(5), 1936-1947.
30. Schultz, W.; Dayan, P.; Montague, P.R. A neural substrate of prediction and reward. Science, 1997, 275(5306), 1593-1599.
31. Clark, J.J.; Sandberg, S.G.; Wanat, M.J.; Gan, J.O.; Horne, E.A.; Hart, A.S.; Akers, C.A.; Parker, J.G.; Willuhn, I.; Martinez, V.; Evans, S.B.; Stella, N.; Phillips, P.E. Chronic microsensors for longitudinal, subsecond dopamine detection in behaving animals. Nat. Methods, 2010, 7(2), 126-129.
32. Dalley, J.W.; Chudasama, Y.; Theobald, D.E.; Pettifer, C.L.; Fletcher, C.M.; Robbins, T.W. Nucleus accumbens dopamine and discriminated approach learning: interactive effects of 6-hydroxydopamine lesions and systemic apomorphine administration. Psychopharmacology(Berl.), 2002, 161(4), 425-433.
33. Parkinson, J.A.; Dalley, J.W.; Cardinal, R.N.; Bamford, A.; Fehnert, B.; Lachenal, G.; Rudarakanchana, N.; Halkerston, K.M.; Robbins, T.W.; Everitt, B.J. Nucleus accumbens dopamine depletion impairs both acquisition and performance of appetitive Pavlovian approach behaviour: implications for mesoaccumbens dopamine function. Behav. Brain Res., 2002, 137(1-2), 149-163.
34. Flagel, S.B.; Clark, J.J.; Robinson, T.E.; Mayo, L.; Czuj, A.; Willuhn, I.; Akers, C.A.; Clinton, S.M.; Phillips, P.E.; Akil, H. A selective role for dopamine in stimulus-reward learning. Nature, 2011, 469(7328), 53-57.
35. Pessiglione, M.; Seymour, B.; Flandin, G.; Dolan, R.J.; Frith, C.D. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature, 2006, 442(7106), 1042-1045.
36. Horvitz, J.C. Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience, 2000, 96(4), 651-656.
37. Redgrave, P.; Prescott, T.J.; Gurney, K. Is the short-latency dopamine response too short to signal reward error? Trends Neurosci., 1999, 22(4), 146-151.
38. Bromberg-Martin, E.S.; Hikosaka, O. Midbrain dopamine neurons signal preference for advance information about upcoming rewards. Neuron, 2009, 63(1), 119-126.
39. Brischoux, F.; Chakraborty, S.; Brierley, D.I.; Ungless, M.A. Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc. Natl. Acad. Sci. USA, 2009, 106(12), 4894-4899.
40. Matsumoto, M.; Hikosaka, O. Two types of dopamine neuron distinctly convey positive and negative motivational signals. Nature, 2009, 459(7248), 837-841.
41. Bromberg-Martin, E.S.; Hikosaka, O. Lateral habenula neurons signal errors in the prediction of reward information. Nat. Neurosci., 2011, 14(9), 1209-1216.
42. Walton, M.E.; Gan, J.O.; Phillips, P.E. The influence of dopamine in generating action from motivation. In: Neural Basis of Motivation and Cognitive Control, Mars, R.B.; Sallet, J.; Rushworth, M.F.; Yeung, N., Eds. MIT Press: Cambridge, in press.
43. Salamone, J.D.; Cousins, M.S.; McCullough, L.D.; Carriero, D.L.; Berkowitz, R.J. Nucleus accumbens dopamine release increases during instrumental lever pressing for food but not free food consumption. Pharmacol. Biochem. Behav., 1994, 49(1), 25-31.
44. Jocham, G.; Klein, T.A.; Ullsperger, M. Dopamine-mediated reinforcement learning signals in the striatum and ventromedial prefrontal cortex underlie value-based choices. J. Neurosci., 2011, 31(5), 1606-1613.
45. St Onge, J.R.; Abhari, H.; Floresco, S.B. Dissociable contributions by prefrontal D1 and D2 receptors to risk-based decision making. J. Neurosci., 2011, 31(23), 8625-8633.
46. Egan, M.F.; Goldberg, T.E.; Kolachana, B.S.; Callicott, J.H.; Mazzanti, C.M.; Straub, R.E.; Goldman, D.; Weinberger, D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. USA, 2001, 98(12), 6917-6922x.
47. Knutson, B.; Cooper, J.C. Functional magnetic resonance imaging of reward prediction. Curr. Opin. Neurol., 2005, 18(4), 411-417.
48. Yacubian, J.; Sommer, T.; Schroeder, K.; Glascher, J.; Kalisch, R.; Leuenberger, B.; Braus, D.F.; Buchel, C. Gene-gene interaction associated with neural reward sensitivity. Proc. Natl. Acad. Sci. USA, 2007, 104(19), 8125-8130.
49. Dreher, J.C.; Kohn, P.; Kolachana, B.; Weinberger, D.R.; Berman, K.F. Variation in dopamine genes influences responsivity of the human reward system. Proc. Natl. Acad. Sci. USA, 2009, 106(2), 617-622.
50. Schmack, K.; Schlagenhauf, F.; Sterzer, P.; Wrase, J.; Beck, A.; Dembler, T.; Kalus, P.; Puls, I.; Sander, T.; Heinz, A.; Gallinat, J. Catechol-O-methyltransferase val158met genotype influences neural processing of reward anticipation. Neuroimage, 2008, 42(4), 1631-1638.
51. Drabant, E.M.; Hariri, A.R.; Meyer-Lindenberg, A.; Munoz, K.E.; Mattay, V.S.; Kolachana, B.S.; Egan, M.F.; Weinberger, D.R. Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch. Gen. Psychiatry, 2006, 63(12), 1396-1406.
52. Smolka, M.N.; Schumann, G.; Wrase, J.; Grusser, S.M.; Flor, H.; Mann, K.; Braus, D.F.; Goldman, D.; Buchel, C.; Heinz, A. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J. Neurosci., 2005, 25(4), 836-842.
53. Tunbridge, E.M.; Harrison, P.J.; Weinberger, D.R. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol. Psychiatry, 2006, 60(2), 141-151.
54. Tversky, A.; Kahneman, D. The framing of decisions and the psychology of choice. Science, 1981, 211(4481), 453-458.
55. Fuke, S.; Suo, S.; Takahashi, N.; Koike, H.; Sasagawa, N.; Ishiura, S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J., 2001, 1(2), 152-156.
56. Dillon, D.G.; Bogdan, R.; Fagerness, J.; Holmes, A.J.; Perlis, R.H.; Pizzagalli, D.A. Variation in TREK1 gene linked to depressionresistant phenotype is associated with potentiated neural responses to rewards in humans. Hum. Brain Mapp., 2010, 31(2), 210-221.
57. Tan, H.Y.; Callicott, J.H.; Weinberger, D.R. Prefrontal cognitive systems in schizophrenia: towards human genetic brain mechanisms. Cogn. Neuropsychiatry, 2009, 14(4-5), 277-298.
58. Marco-Pallares, J.; Cucurell, D.; Cunillera, T.; Kramer, U.M.; Camara, E.; Nager, W.; Bauer, P.; Schule, R.; Schols, L.; Munte, T.F.; Rodriguez-Fornells, A. Genetic variability in the dopamine system (dopamine receptor D4, catechol-O-methyltransferase) modulates neurophysiological responses to gains and losses. Biol. Psychiatry, 2009, 66(2), 154-161.
59. Gehring, W.J.; Willoughby, A.R. The medial frontal cortex and the rapid processing of monetary gains and losses. Science, 2002, 295(5563), 2279-2282.
60. Camara, E.; Kramer, U.M.; Cunillera, T.; Marco-Pallares, J.; Cucurell, D.; Nager, W.; Mestres-Misse, A.; Bauer, P.; Schule, R.; Schols, L.; Tempelmann, C.; Rodriguez-Fornells, A.; Munte, T.F. The effects of COMT (Val108/158Met) and DRD4(SNP -521) dopamine genotypes on brain activations related to valence and magnitude of rewards. Cereb. Cortex, 2010, 20(8), 1985-1996.
61. Forbes, E.E.; Brown, S.M.; Kimak, M.; Ferrell, R.E.; Manuck, S.B.; Hariri, A.R. Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol. Psychiatry, 2009, 14(1), 60-70.
62. Nikolova, Y.S.; Ferrell, R.E.; Manuck, S.B.; Hariri, A.R. Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity. Neuropsychopharmacology, 2011, 36(9), 1940-1947.
63. Rushworth, M.F.; Behrens, T.E.; Rudebeck, P.H.; Walton, M.E. Contrasting roles for cingulate and orbitofrontal cortex in decisions and social behaviour. Trends Cogn. Sci., 2007, 11(4), 168-176.
64. Wichers, M.; Aguilera, M.; Kenis, G.; Krabbendam, L.; Myin-Germeys, I.; Jacobs, N.; Peeters, F.; Derom, C.; Vlietinck, R.; Mengelers, R.; Delespaul, P.; van Os, J. The catechol-O-methyl transferase Val158Met polymorphism and experience of reward in the flow of daily life. Neuropsychopharmacology, 2008, 33(13), 3030-3036.
65. Mier, D.; Kirsch, P.; Meyer-Lindenberg, A. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol. Psychiatry, 2010, 15, 918-927.
66. Frank, M.J.; Moustafa, A.A.; Haughey, H.M.; Curran, T.; Hutchison, K.E. Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning. Proc. Natl. Acad. Sci. USA, 2007, 104(41), 16311-16316.
67. Frank, M.J.; Seeberger, L.C.; O'Reilly R.C. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science, 2004, 306(5703), 1940-1943.
68. Doll, B.B.; Hutchison, K.E.; Frank, M.J. Dopaminergic genes predict individual differences in susceptibility to confirmation bias. J. Neurosci., 2011, 31(16), 6188-6198.
69. Frank, M.J.; Doll, B.B.; Oas-Terpstra, J.; Moreno, F. Prefrontal and striatal dopaminergic genes predict individual differences in exploration and exploitation. Nat. Neurosci., 2009, 12(8), 1062-1068.
70. Krugel, L.K.; Biele, G.; Mohr, P.N.; Li, S.C.; Heekeren, H.R. Genetic variation in dopaminergic neuromodulation influences the ability to rapidly and flexibly adapt decisions. Proc. Natl. Acad. Sci. USA, 2009, 106(42), 17951-17956.
71. Boettiger, C.A.; Mitchell, J.M.; Tavares, V.C.; Robertson, M.; Joslyn, G.; D'Esposito, M.; Fields, H.L. Immediate reward bias in humans: fronto-parietal networks and a role for the catechol-O-methyltransferase 158(Val/Val) genotype. J. Neurosci., 2007, 27(52), 14383-14391.
72. Paloyelis, Y.; Asherson, P.; Mehta, M.A.; Faraone, S.V.; Kuntsi, J. DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls. Neuropsychopharmacology, 2010, 35(12), 2414-2426.
73. Tunbridge, E.M.; Weickert, C.S.; Kleinman, J.E.; Herman, M.M.; Chen, J.; Kolachana, B.S.; Harrison, P.J.; Weinberger, D.R. Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. Cereb. Cortex, 2007, 17(5), 1206-1212.
74. Lewis, D.A. Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology, 1997, 16(6), 385-398.
75. Di Chiara, G.; Imperato, A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA, 1988, 85(14), 5274-5278.
76. Hyman, S.E.; Malenka, R.C.; Nestler, E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci., 2006, 29, 565-598.
77. Tammimaki, A.E.; Mannisto, P.T. Are genetic variants of COMT associated with addiction? Pharmacogenet. Genomics, 2010, 20(12), 717-741.
78. Nutt, D.J.; Law, F.D. Pharmacological and psychological aspects of drug abuse. In: New Oxford Textbook of Psychiatry; Gelder, M.G.; Andreasen, N.C.; Lopez-Ibor, Jr., J.J.; Geddes, J.R., Eds. Oxford University Press: Oxford, 2009, pp. 426-432.
79. Palmatier, M.A.; Pakstis, A.J.; Speed, W.; Paschou, P.; Goldman, D.; Odunsi, A.; Okonofua, F.; Kajuna, S.; Karoma, N.; Kungulilo, S.; Grigorenko, E.; Zhukova, O.V.; Bonne-Tamir, B.; Lu, R.B.; Parnas, J.; Kidd, J.R.; DeMille, M.M.; Kidd, K.K. COMT haplotypes suggest P2 promoter region relevance for schizophrenia. Mol. Psychiatry, 2004, 9(9), 859-870.
80. Tammimaki, A.; Forsberg, M.M.; Karayiorgou, M.; Gogos, J.A.; Mannisto, P.T. Increase in free choice oral ethanol selfadministration in catechol-o-methyltransferase gene-disrupted male mice. Basic Clin. Pharmacol. Toxicol., 2008, 103(4), 297-304.
81. Kauhanen, J.; Hallikainen, T.; Tuomainen, T.P.; Koulu, M.; Karvonen, M.K.; Salonen, J.T.; Tiihonen, J. Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. Alcohol Clin. Exp. Res., 2000, 24(2), 135-139.
82. Li, T.; Chen, C.K.; Hu, X.; Ball, D.; Lin, S.K.; Chen, W.; Sham, P.C.; Loh el, W.; Murray, R.M.; Collier, D.A. Association analysis of the DRD4 and COMT genes in methamphetamine abuse. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2004, 129B(1), 120-124.
83. Jugurnauth, S.K.; Chen, C.K.; Barnes, M.R.; Li, T.; Lin, S.K.; Liu, H.C.; Collier, D.A.; Breen, G. A COMT gene haplotype associated with methamphetamine abuse. Pharmacogenet. Genomics, 2011, 21(11), 731-740.
84. Huotari, M.; Garcia-Horsman, J.A.; Karayiorgou, M.; Gogos, J.A.; Mannisto, P.T. D-amphetamine responses in catechol-O-methyltransferase (COMT) disrupted mice. Psychopharmacology(Berl.), 2004, 172(1), 1-10.
85. Huotari, M.; Santha, M.; Lucas, L.R.; Karayiorgou, M.; Gogos, J.A.; Mannisto, P.T. Effect of dopamine uptake inhibition on brain catecholamine levels and locomotion in catechol-O-methyltransferase-disrupted mice. J. Pharmacol. Exp. Ther., 2002, 303(3), 1309-1316.
86. O'Tuathaigh, C.M.; Hryniewiecka, M.; Behan, A.; Tighe, O.; Coughlan, C.; Desbonnet, L.; Cannon, M.; Karayiorgou, M.; Gogos, J.A.; Cotter, D.R.; Waddington, J.L. Chronic adolescent exposure to Delta-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes. Neuropsychopharmacology, 2010, 35(11), 2262-2273.
87. Caspi, A.; Moffitt, T.E.; Cannon, M.; McClay, J.; Murray, R.; Harrington, H.; Taylor, A.; Arseneault, L.; Williams, B.; Braithwaite, A.; Poulton, R.; Craig, I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol. Psychiatry, 2005, 57(10), 1117-1127.
88. Henquet, C.; Rosa, A.; Krabbendam, L.; Papiol, S.; Fananas, L.; Drukker, M.; Ramaekers, J.G.; van Os, J. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology, 2006, 31(12), 2748-2757.
89. Henquet, C.; Rosa, A.; Delespaul, P.; Papiol, S.; Fananas, L.; van Os, J.; Myin-Germeys, I. COMT ValMet moderation of cannabisinduced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life. Acta Psychiatr. Scand., 2009, 119(2), 156-160.
90. Zammit, S.; Owen, M.J.; Evans, J.; Heron, J.; Lewis, G. Cannabis, COMT and psychotic experiences. Br. J. Psychiatry, 2011, 199, 380-385.
91. Rakvag, T.T.; Klepstad, P.; Baar, C.; Kvam, T.M.; Dale, O.; Kaasa, S.; Krokan, H.E.; Skorpen, F. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain, 2005, 116(1-2), 73-78.
92. Rakvag, T.T.; Ross, J.R.; Sato, H.; Skorpen, F.; Kaasa, S.; Klepstad, P. Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain. Mol. Pain, 2008, 4, 64.
93. Ross, J.R.; Riley, J.; Taegetmeyer, A.B.; Sato, H.; Gretton, S.; du Bois, R.M.; Welsh, K.I. Genetic variation and response to morphine in cancer patients: catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects. Cancer, 2008, 112(6), 1390-1403.
94. Zubieta, J.K.; Heitzeg, M.M.; Smith, Y.R.; Bueller, J.A.; Xu, K.; Xu, Y.; Koeppe, R.A.; Stohler, C.S.; Goldman, D. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science, 2003, 299(5610), 1240-1243.
95. Johnstone, E.C.; Elliot, K.M.; David, S.P.; Murphy, M.F.; Walton, R.T.; Munafo, M.R. Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol. Biomarkers Prev., 2007, 16(6), 1065-1069.
96. Colilla, S.; Lerman, C.; Shields, P.G.; Jepson, C.; Rukstalis, M.; Berlin, J.; DeMichele, A.; Bunin, G.; Strom, B.L.; Rebbeck, T.R. Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenet. Genomics, 2005, 15(6), 393-398.
97. Munafo, M.R.; Johnstone, E.C.; Guo, B.; Murphy, M.F.; Aveyard, P. Association of COMT Val108/158Met genotype with smoking cessation. Pharmacogenet. Genomics, 2008, 18(2), 121-128.
98. Threlfell, S.; Cragg, S.J. Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons. Front. Syst. Neurosci., 2011, 5, 11.
99. Brody, A.L.; Mandelkern, M.A.; Olmstead, R.E.; Scheibal, D.; Hahn, E.; Shiraga, S.; Zamora-Paja, E.; Farahi, J.; Saxena, S.; London, E.D.; McCracken, J.T. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch. Gen. Psychiatry, 2006, 63(7), 808-816.
100. Loughead, J.; Wileyto, E.P.; Valdez, J.N.; Sanborn, P.; Tang, K.; Strasser, A.A.; Ruparel, K.; Ray, R.; Gur, R.C.; Lerman, C. Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype. Mol. Psychiatry, 2009, 14(8), 820-826.
101. Palmatier, M.A.; Kang, A.M.; Kidd, K.K. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol. Psychiatry, 1999, 46(4), 557-567.
102. Harrison, P.J.; Tunbridge, E.M. Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology, 2008, 33(13), 3037-3045.
103. Carr, D.B.; Sesack, S.R. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci., 2000, 20(10), 3864-3873.
104. Blasi, G.; Mattay, V.S.; Bertolino, A.; Elvevag, B.; Callicott, J.H.; Das, S.; Kolachana, B.S.; Egan, M.F.; Goldberg, T.E.; Weinberger, D.R. Effect of catechol-O-methyltransferase val158met genotype on attentional control. J. Neurosci., 2005, 25(20), 5038-5045.
105. Ishiguro, H.; Haruo Shibuya, T.; Toru, M.; Saito, T.; Arinami, T. Association study between high and low activity polymorphism of catechol-O-methyltransferase gene and alcoholism. Psychiatr. Genet., 1999, 9(3), 135-138.
106. Hallikainen, T.; Lachman, H.; Saito, T.; Volavka, J.; Kauhanen, J.; Salonen, J.T.; Ryynänen, O.P.; Koulu, M.; Karvonen, M.K.; Pohjalainen, T.; Syvälahti, E.; Hiet-aletal/et-ala, J.; Tiihonen, J. Lack of association between the functional variant of the catechol-o-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior. Am. J. Med. Genet., 2000, 96(3), 348-352.
107. Henderson, A.S.; Korten, A.E.; Jorm, A.F.; Jacomb, P.A.; Christensen, H.; Rodgers, B.; Tan, X.; Easteal, S. COMT and DRD3 polymorphisms, environmental exposures, and personality traits related to common mental disorders. Am. J. Med. Genet., 2000, 96(1), 102-107.
108. Nakamura, A.; Inada, T.; Kitao, Y.; Katayama, Y. Association between catechol-O-methyltransferase (COMT) polymorphism and severe alcoholic withdrawal symptoms in male Japanese alcoholics. Addict. Biol., 2001, 6(3), 233-238.
109. Wang, T.; Franke, P.; Neidt, H.; Cichon, S.; Knapp, M.; Lichtermann, D.; Maier, W.; Propping, P.; Nöthen, M.M. Association study of the low-activity allele of catechol-O-methyltransferase and alcoholism using a family-based approach. Mol. Psychiatry, 2001, 6(1), 109-111.
110. Köhnke, M.D.; Wiatr, G.; Kolb, W.; Köhnke, A.M.; Schick, S.; Lutz, U.; Vonthein, R.; Gaertner, I. Plasma homovanillic acid: a significant association with alcoholism is independent of a functional polymorphism of the human catechol-O-methyltransferase gene. Neuropsychopharmacology, 2003, 28(5), 1004-1010.
111. Kweon, Y.S.; Lee, H.K.; Lee, C.T.; Pae, C.U. Association study of catechol-O-methyltransferase gene polymorphism in Korean male alcoholics. Psychiatr. Genet., 2005, 15(2), 151-154.
112. Enoch, M.A.; Waheed, J.F.; Harris, C.R.; Albaugh, B.; Goldman, D. Sex differences in the influence of COMT Val158Met on alcoholism and smoking in plains American Indians. Alcohol Clin. Exp. Res., 2006, 30(3), 399-406.
113. Samochowiec, J.; Kucharska-Mazur, J.; Grzywacz, A.; Jabłoński, M.; Rommelspacher, H.; Samochowiec, A.; Sznabowicz, M.; Horodnicki, J.; Sagan, L.; Pełka-Wysiecka, J. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence. Neurosci. Lett., 2006, 410(1), 1-5.
114. Ser, O.; Didden, W.; Mikes, V.; Pitelová, R.; Znojil, V.; Zvolsk, P. The association between high-activity COMT allele and alcoholism. Neuroendocrinol. Lett., 2006, 27(1-2), 231-235.
115. Foroud, T.; Wetherill, L.F.; Dick, D.M.; Hesselbrock, V.; Nurnberger, J.I.; Kramer, J.; Tischfield, J.; Schuckit, M.; Bierut, L.J.; Xuei, X.; Edenberg, H.J. Lack of association of alcohol dependence and habitual smoking with catechol-O-methyltransferase. Alcohol Clin. Exp. Res., 2007, 31(11), 1773-1779.
116. Samochowiec, J.; Kucharska-Mazur, J.; Grzywacz, A.; Pelka-Wysiecka, J.; Mak, M.; Samochowiec, A.; Bienkowski, P. Genetics of Lesch's typology of alcoholism. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2008, 32(2), 423-427.
117. Kibitov, A.O.; Voskoboeva, E. I.u.; Brodianski, V.M.; Chuprova, N.A.; Smirnova, E.V. Association study of the Val158Met polymorphism of the catechol-O-methyltransferase gene and alcoholism and heroin dependence: the role of a family history. Zh. Nevrol. Psikhiatr. Im. S.S. Korsakova, 2010, 110(4), 84-88.
118. Nedic, G.; Nikolac, M.; Sviglin, K.N.; Muck-Seler, D.; Borovecki, F.; Pivac, N. Association study of a functional catechol-O-methyltransferase (COMT) Val108/158Met polymorphism and suicide attempts in patients with alcohol dependence. Int. J. Neuropsychopharmacol., 2011, 14(3), 377-388.
119. Voisey, J.; Swagell, C.D.; Hughes, I.P.; Lawford, B.R.; Young, R.M.; Morris, C.P. A novel SNP in COMT is associated with alcohol dependence but not opiate or nicotine dependence: a case control study. Behav. Brain Funct., 2011, 7, 51.
120. Caspi, A.; Moffitt, T.E.; Cannon, M.; McClay, J.; Murray, R.; Harrington, H.; Taylor, A.; Arseneault, L.; Williams, B.; Braithwaite, A.; Poulton, R.; Craig, I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol. Psychiatry, 2005, 57(10), 1117-1127.
121. Baransel Isir, A.B.; Oguzkan, S.; Nacak, M.; Gorucu, S.; Dulger, H.E.; Arslan, A. The catechol-O-methyl transferase Val158Met polymorphism and susceptibility to cannabis dependence. Am. J. Forensic Med. Pathol., 2008, 29(4), 320-322.
122. Cuyas, E.; Verdejo-Garcia, A.; Fagundo, A.B.; Khymenets, O.; Rodriguez, J.; Cuenca, A.; de Sola Llopis, S.; Langohr, K.; Pena-Casanova, J.; Torrens, M.; Martin-Santos, R.; Farre, M.; de la Torre, R. The influence of genetic and environmental factors among MDMA users in cognitive performance. PLoS ONE, 2011, 6(11), e27206.
123. Li, T.; Chen, C.K.; Hu, X.; Ball, D.; Lin, S.K.; Chen, W.; Sham, P.C.; Loh, e.-W.; Murray, R.M.; Collier, D.A. Association analysis of the DRD4 and COMT genes in methamphetamine abuse. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2004, 129B(1), 120-124.
124. Suzuki, A.; Nakamura, K.; Sekine, Y.; Minabe, Y.; Takei, N.; Suzuki, K.; Iwata, Y.; Kawai, M.; Takebayashi, K.; Matsuzaki, H.; Iyo, M.; Ozaki, N.; Inada, T.; Iwata, N.; Harano, M.; Komiyama, T.; Yamada, M.; Sora, I.; Ujike, H.; Mori, N. An association study between catechol-O-methyl transferase gene polymorphism and methamphetamine psychotic disorder. Psychiatr. Genet., 2006, 16(4), 133-138.
125. Bousman, C.A.; Cherner, M.; Atkinson, J.H.; Heaton, R.K.; Grant, I.; Everall, I.P.; Hnrc group, T. COMT Val158Met polymorphism, executive dysfunction, and sexual risk behavior in the context of hiv infection and methamphetamine dependence. Interdiscip. Perspect. Infect. Dis., 2010, 2010, 678648.
126. Bousman, C.A.; Glatt, S.J.; Cherner, M.; Atkinson, J.H.; Grant, I.; Tsuang, M.T.; Everall, I.P.; Group, H. Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. Psychiatry Res., 2010, 178(2), 295-298.
127. Jugurnauth, S.K.; Chen, C.K.; Barnes, M.R.; Li, T.; Lin, S.K.; Liu, H.C.; Collier, D.A.; Breen, G. A COMT gene haplotype associated with methamphetamine abuse. Pharmacogenet. Genomics, 2011, 21(11), 731-740.
128. Vandenbergh, D.J.; Rodriguez, L.A.; Miller, I.T.; Uhl, G.R.; Lachman, H.M. High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am. J. Med. Genet., 1997, 74(4), 439-442.
129. Conner, B.T.; Hellemann, G.S.; Ritchie, T.L.; Noble, E.P. Genetic, personality, and environmental predictors of drug use in adolescents. J. Subst. Abuse Treat., 2010, 38(2), 178-190.
130. Horowitz, R.; Kotler, M.; Shufman, E.; Aharoni, S.; Kremer, I.; Cohen, H.; Ebstein, R.P. Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a familybased haplotype relative risk study. Am. J. Med. Genet., 2000, 96(5), 599-603.
131. Oosterhuis, B.E.; LaForge, K.S.; Proudnikov, D.; Ho, A.; Nielsen, D.A.; Gianotti, R.; Barral, S.; Gordon, D.; Leal, S.M.; Ott, J.; Kreek, M.J. Catechol-O-methyltransferase (COMT) gene variants: possible association of the Val158Met variant with opiate addiction in Hispanic women. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2008, 147B(6), 793-798.
132. Demetrovics, Z.; Varga, G.; Szekely, A.; Vereczkei, A.; Csorba, J.; Balazs, H.; Hoffman, K.; Sasvari-Szekely, M.; Barta, C. Association between Novelty Seeking of opiate-dependent patients and the catechol-O-methyltransferase Val(158)Met polymorphism. Compr. Psychiatry, 2010, 51(5), 510-515.
133. Lohoff, F.W.; Weller, A.E.; Bloch, P.J.; Nall, A.H.; Ferraro, T.N.; Kampman, K.M.; Pettinati, H.M.; Oslin, D.W.; Dackis, C.A.; O'Brien, C.P.; Berrettini, W.H. Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence. Neuropsychopharmacology, 2008, 33(13), 3078-3084.
134. David, S.P.; Johnstone, E.; Griffiths, S.E.; Murphy, M.; Yudkin, P.; Mant, D.; Walton, R. No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation. Pharmacogenetics, 2002, 12(3), 265-268.
135. Colilla, S.; Lerman, C.; Shields, P.G.; Jepson, C.; Rukstalis, M.; Berlin, J.; DeMichele, A.; Bunin, G.; Strom, B.L.; Rebbeck, T.R. Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenet. Genomics, 2005, 15(6), 393-398.
136. Redden, D.T.; Shields, P.G.; Epstein, L.; Wileyto, E.P.; Zakharkin, S.O.; Allison, D.B.; Lerman, C. Catechol-O-methyl-transferase functional polymorphism and nicotine dependence: an evaluation of nonreplicated results. Cancer Epidemiol. Biomarkers Prev., 2005, 14(6), 1384-1389.
137. Beuten, J.; Payne, T.J.; Ma, J.Z.; Li, M.D. Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. Neuropsychopharmacology, 2006, 31(3), 675-684.
138. Berrettini, W.H.; Wileyto, E.P.; Epstein, L.; Restine, S.; Hawk, L.; Shields, P.; Niaura, R.; Lerman, C. Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. Biol. Psychiatry, 2007, 61(1), 111-118.
139. Guo, S.; Chen, D.F.; Zhou, D.F.; Sun, H.Q.; Wu, G.Y.; Haile, C.N.; Kosten, T.A.; Kosten, T.R.; Zhang, X.Y. Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers. Psychopharmacology(Berl.), 2007, 190(4), 449-456.
140. Johnstone, E.C.; Elliot, K.M.; David, S.P.; Murphy, M.F.; Walton, R.T.; Munafò, M.R. Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol. Biomarkers Prev., 2007, 16(6), 1065-1069.
141. Saccone, S.F.; Hinrichs, A.L.; Saccone, N.L.; Chase, G.A.; Konvicka, K.; Madden, P.A.; Breslau, N.; Johnson, E.O.; Hatsukami, D.; Pomerleau, O.; Swan, G.E.; Goate, A.M.; Rutter, J.; Bertelsen, S.; Fox, L.; Fugman, D.; Martin, N.G.; Montgomery, G.W.; Wang, J.C.; Ballinger, D.G.; Rice, J.P.; Bierut, L.J. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum. Mol. Genet., 2007, 16(1), 36-49.
142. Tochigi, M.; Suzuki, K.; Kato, C.; Otowa, T.; Hibino, H.; Umekage, T.; Kato, N.; Sasaki, T. Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior. Pharmacogenet. Genomics, 2007, 17(10), 867-872.
143. Ton, T.G.; Rossing, M.A.; Bowen, D.J.; Srinouanprachan, S.; Wicklund, K.; Farin, F.M. Genetic polymorphisms in dopaminerelated genes and smoking cessation in women: a prospective cohort study. Behav. Brain Funct., 2007, 3, 22.
144. Han, D.H.; Joe, K.H.; Na, C.; Lee, Y.S. Effect of genetic polymorphisms on smoking cessation: a trial of bupropion in Korean male smokers. Psychiatr. Genet., 2008, 18(1), 11-16.
145. Munafò, M.R.; Johnstone, E.C.; Guo, B.; Murphy, M.F.; Aveyard, P. Association of COMT Val108/158Met genotype with smoking cessation. Pharmacogenet. Genomics, 2008, 18(2), 121-128.
146. Shiels, M.S.; Huang, H.Y.; Hoffman, S.C.; Shugart, Y.Y.; Bolton, J.H.; Platz, E.A.; Helzlsouer, K.J.; Alberg, A.J. A communitybased study of cigarette smoking behavior in relation to variation in three genes involved in dopamine metabolism: Catechol-O-methyltransferase (COMT), dopamine beta-hydroxylase (DBH) and monoamine oxidase-A (MAO-A). Prev. Med., 2008, 47(1), 116-122.
147. Amstadter, A.B.; Nugent, N.R.; Koenen, K.C.; Ruggiero, K.J.; Acierno, R.; Galea, S.; Kilpatrick, D.G.; Gelernter, J. Association between COMT, PTSD, and increased smoking following hurricane exposure in an epidemiologic sample. Psychiatry, 2009, 72(4), 360-369.
148. Breitling, L.P.; Dahmen, N.; Illig, T.; Rujescu, D.; Nitz, B.; Raum, E.; Winterer, G.; Rothenbacher, D.; Brenner, H. Variants in COMT and spontaneous smoking cessation: retrospective cohort analysis of 925 cessation events. Pharmacogenet. Genomics, 2009, 19(8), 657-659.
149. Tang, X.; Guo, S.; Sun, H.; Song, X.; Jiang, Z.; Sheng, L.; Zhou, D.; Hu, Y.; Chen, D. Gene-gene interactions of CYP2A6 and MAOA polymorphisms on smoking behavior in Chinese male population. Pharmacogenet. Genomics, 2009, 19(5), 345-352.
150. Omidvar, M.; Stolk, L.; Uitterlinden, A.G.; Hofman, A.; Van Duijn, C.M.; Tiemeier, H. The effect of catechol-O-methyltransferase Met/Val functional polymorphism on smoking cessation: retrospective and prospective analyses in a cohort study. Pharmacogenet. Genomics, 2009, 19(1), 45-51.
151. De Ruyck, K.; Nackaerts, K.; Beels, L.; Werbrouck, J.; De Volder, A.; Meysman, M.; Salhi, B.; Van Meerbeeck, J.; Thierens, H. Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients. Pharmacogenomics, 2010, 11(8), 1053-1063.
152. Gu, Z.; Feng, X.; Dong, X.; Chan, P. Smoking, genes encoding dopamine pathway and risk for Parkinson's disease. Neurosci. Lett., 2010, 482(1), 31-34.
153. Greenbaum, L.; Kanyas, K.S.; Rigbi, A.; Alkelai, A.; Kohn, Y.; Lerer, B. Why do young women smoke? VII COMT as a risk modifying gene for Nicotine dependence - role of gene-gene interaction, personality, and environmental factors. Hum. Psychopharmacol., 2010, 25(7-8), 536-542.
154. Nedic, G.; Nikolac, M.; Borovecki, F.; Hajnsek, S.; Muck-Seler, D.; Pivac, N. Association study of a functional catechol-O-methyltransferase polymorphism and smoking in healthy Caucasian subjects. Neurosci. Lett., 2010, 473(3), 216-219.
155. Munafò, M.R.; Freathy, R.M.; Ring, S.M.; St Pourcain, B.; Smith, G.D. Association of COMT Val(108/158)Met genotype and cigarette smoking in pregnant women. Nicotine Tob. Res., 2011, 13(2), 55-63.